Novartis’ NVA237 improves lung function in pulmonary disease patients
Swiss drug maker Novartis said results from a phase three study remarkably improved lung function in a similar way to a rival drug.
Read more »Inherent value to be “developed and extracted” at Amphion
Amphion Innovations (LON:AMP) said it believes there is “significant inherent value to be developed and extracted” from its partner companies, […]
Read more »Clinical Trials Managed in “The Cloud?”
The fundamental concept of cloud computing dates back to the 1960s, when John McCarthy was quoted as saying “computation may someday be organized as public utility.”
Read more »Protected: OneMedRadio: The JOBS Act — Promises and Pitfalls
There is no excerpt because this is a protected post.
Read more »Critical Sales and Distribution Considerations for the Buyer, Investor and Seller
For many emerging companies, one of their largest financial investments and most important strategic decisions is their approach to sales and distribution.
Read more »CEO Interview: Larry Birch Discusses DataTRAK Collaboration and Patent Suit
After bringing his clinical research software company back from near bankruptcy to steady profitability in 2010, CEO Larry Birch is going on the offensive.
Read more »July 14 2011 Proactive Investors One2One Investor Forum
Thursday the 14th July 2011, Intercontinental New York Barclay Hotel, 111 East 48th Street, New York The directors of IntelliCell […]
Read more »Neostem’s Suzhou Eyre receives Chinese Regulatory Approval For 6th Production Line
NeoStem announced Monday that its subsidiary, Suzhou Eyre Pharmaceuticals, has received approval for its sixth production line.
Read more »e-Zassi To Present Solution To Fractured Medical Device Ecosystem
e-Zassi is the medical device industry’s first subscription-based, decision support software and technology marketplace.
Read more »July 28 Annual Wall Street Unplugged
The Management’s Guide to Wall Street & the Capital Markets Thursday, July 28th, 2011 – New York City Gansevoort Park […]
Read more »